FR2872429B1 - Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif - Google Patents

Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif

Info

Publication number
FR2872429B1
FR2872429B1 FR0407403A FR0407403A FR2872429B1 FR 2872429 B1 FR2872429 B1 FR 2872429B1 FR 0407403 A FR0407403 A FR 0407403A FR 0407403 A FR0407403 A FR 0407403A FR 2872429 B1 FR2872429 B1 FR 2872429B1
Authority
FR
France
Prior art keywords
manufacturing
active ingredient
controlled release
release pharmaceutical
form containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0407403A
Other languages
English (en)
Other versions
FR2872429A1 (fr
Inventor
Saint Jean Catherine Lacaze
Luc Grislain
Thomas Bergua
Francois Boutignon
Gerard Demazeau
Alain Largeteau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ellipse Pharmaceuticals SAS
Original Assignee
Ellipse Pharmaceuticals SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ellipse Pharmaceuticals SAS filed Critical Ellipse Pharmaceuticals SAS
Priority to FR0407403A priority Critical patent/FR2872429B1/fr
Publication of FR2872429A1 publication Critical patent/FR2872429A1/fr
Application granted granted Critical
Publication of FR2872429B1 publication Critical patent/FR2872429B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0407403A 2004-07-02 2004-07-02 Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif Expired - Fee Related FR2872429B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0407403A FR2872429B1 (fr) 2004-07-02 2004-07-02 Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0407403A FR2872429B1 (fr) 2004-07-02 2004-07-02 Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif

Publications (2)

Publication Number Publication Date
FR2872429A1 FR2872429A1 (fr) 2006-01-06
FR2872429B1 true FR2872429B1 (fr) 2008-05-09

Family

ID=34948924

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0407403A Expired - Fee Related FR2872429B1 (fr) 2004-07-02 2004-07-02 Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif

Country Status (1)

Country Link
FR (1) FR2872429B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880273B1 (fr) * 2004-12-30 2007-03-30 Ceva Sante Animale Sa Procede de separation d'une composition pharmaceutique solide a liberation prolongee et controlee sous hautes pressions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03161429A (ja) * 1989-11-20 1991-07-11 Olympus Optical Co Ltd 薬物徐放材
FR2804326B1 (fr) * 2000-01-27 2002-10-18 Ellipse Pharmaceuticals Procede de sterilisation par traitement sous hautes pressions de principes actifs sensibles
JP4409135B2 (ja) * 2000-12-01 2010-02-03 武田薬品工業株式会社 生理活性物質含有製剤の製造法

Also Published As

Publication number Publication date
FR2872429A1 (fr) 2006-01-06

Similar Documents

Publication Publication Date Title
NO20033244L (no) Farmasöytisk sammensetning som har redusert tendens til legemiddelkrystallisering
MA28641B1 (fr) Procede pour la fabrication d'un vaccin contre la grippe
FR2891459B1 (fr) Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2779651B1 (fr) Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero
MA28721B1 (fr) Procede d'application de pesticides
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
NO20042807L (no) Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser
ITMI20030025A1 (it) Derivati dell'acido idrossammico ad attivita' antinfiammatoria.
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
ATE471930T1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
FR2858556B1 (fr) Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
FR2867682B1 (fr) Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
ATE503749T1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
FR2872429B1 (fr) Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif
ITBO20050705A1 (it) Macchina per la fabbricazione e l'erogazione di frappe' di gelato o schake
FR2869030B1 (fr) Procede de production d'alpha-alumine particulaire
ATE455540T1 (de) Orale dosierform für die kontrollierte arzneimittelfreisetzung
FR2890312B1 (fr) Procede d'obtention d'un principe actif repulpant, principe actif obtenu et compositions cosmetiques l'incluant
FR2886150B1 (fr) Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique
FR2823137B1 (fr) Procede de fabrication de billes d'alginate renfermant au moins un actif cosmetique
FR2887542B1 (fr) Procede d'inertage d'impuretes
FR2842110B1 (fr) Procede de desinfection de locaux d'elevage

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120330